Colostrum Plus with Probiotics
DC $17.00

<PC $20.00>

This 50g powder formula contains:
Colostrum...........................................700mg
Rice Tocotrienols..................................100mg
F.O.S. (Fructo-Oligo-Saccarides...............100mg
Probiotic bacteria...................................75mg
Providing:
Bifidobacterium bifidum .........................0.5 billion
Bifidobacterium infantis ..........................0.5 billion
Lactobaccilus acidophillus ......................0.5 billion
Other ingredients: Stevia and all natural Citrus flavor.
No soy, eff, yeast, wheat, corn, alcohol, artificial colorings, sweeteners or preservatives.

RECOMMENDATIONS: For infants up to 1 year: 1/4 teaspoon daily. For children 1-5 years: 1/2 teaspoon daily. For children 6-12 years: 1/2 teaspoon twice daily.

Supports healthy digestion and the immune system.

Lactobacillus Administration to Infants May Reduce Risk of Early Atopic
Disease
------------------------------------------------------------------------------
WESTPORT, CT (Reuters Health) Apr 05 - Children from families with a history
of atopic disease may be protected from these diseases by giving them the
probiotic Lactobacillus GG early in life, according to a report published in
the April 7th issue of The Lancet.

Dr. Marko Kalliomaki, from Turku University Hospital, in Finland, and
colleagues randomized 159 mothers who had at least one first-degree relative
or partner with atopic eczema, allergic rhinitis or asthma to receive daily
placebo or Lactobacillus GG capsules 2 to 4 weeks prior to expected delivery.
After delivery, breast-feeding mothers and children of nonbreast-feeding
mothers continued the assigned therapy for 6 months.

Of the 132 children who completed the 2-year study, 46 were diagnosed with
eczema, "the main sign of atopic disease in the first years of life.". Six of
these children also met diagnostic criteria for asthma and one child met
criteria for allergic rhinitis.

The researchers found that children who received the probiotic were half as
likely as placebo-receiving children (235 vs. 46%) to develop atopic eczema.

"Our results suggest that gut microflora have unique, yet largely unexplored,
endogenous immunomodulatory properties," the investigators note. "These
properties might be indispensable in the fight against the increasing
frequency of atopic, and possibly other, immunologic diseases."

"As in comedy, the secret of successful immunotherapy may be timing," states
Dr. Simon H. Murch, from the Royal Free and University College School of
Medicine, in London, in a related editorial. The improvement noted in the
current study was "greater than usually seen with probiotic administration
later in life, and larger studies will be required before these agents can be
more widely recommended for perinatal use," he adds.

Lancet 2001;357:1057-1059,1076-1079.

For more information, see Children's Health.

© 2000 www.houseofgoldhealthproducts.com. (888) 889-7882.
This site is protected by copyright and trademark laws under U.S. and international law. All rights reserved.